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Abstract
The prevalence of essential hypertension has continued to increase worldwide, and its
consequences have remained a growing concern. A number of sociodemographic and
clinical variables may however serve as key determinants of the extent to which it is
associated with psychiatric comorbidity as well as impairment of quality of life. The aim
of this study, therefore, was to determine the sociodemographic and clinical factors that
may influence the level of psychiatric comorbidity and quality of life associated with
persons  with  essential  hypertension  attending  the  general  outpatient  clinic  of  the
University of Port Harcourt Teaching Hospital (UPTH). Following ethical approval and
informed consent from the participants, 360 subjects making up the study group were
recruited based on the study’s inclusion and exclusion criteria. A pilot study was carried
out. Subjects were further administered with the study’s instruments including the
socio-demographic/clinical  questionnaire,  GHQ-12,  WHO  Composite  International
Diagnostic Interview (WHOCIDI) and the WHOQOL-Bref. The data were analysed
using the Statistical Package for Social Sciences version 16 statistical package. Confi‐
dence interval was set at 95%, while p-value of less than 0.05 was considered statisti‐
cally significant. The study found a prevalence of psychiatric comorbidity of 64.4%
among the hypertensives. Among the study group, there was no significant relation‐
ship between the presence of psychiatric comorbidity and age class (p = 0.350), gender
(p = 0.22), level of education (p = 043), income class (p = 0.81) and occupation. Persons
who were married were significantly more likely to have a psychiatric comorbidity (p
= 0.001). There was also no significant relationships between age of onset of illness (p =
0.60), duration of illness (p = 0.73), duration of treatment (p = 0.82) and self-stigma (p =
0.15). The findings of this study support the impression that essential hypertension is a
chronic  debilitating  illness,  associated  with  psychiatric  comorbidity  and  reduced
quality of life, that is largely significantly influenced by a number of sociodemograph‐
ic and clinical factors. The results support the call that the management of patients with
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essential  hypertension should include attention  to  the  mental  health  status  of  the
sufferers.
Keywords: pattern and prevalence, essential hypertension, psychiatric comorbidity,
QOL, UPTH
1. Introduction
There is a growing population of persons with essential hypertension (HT) worldwide despite
all efforts at increasing education and awareness about it [1–19]. World Health Organization
(WHO) estimates that non-communicable diseases like hypertension and other heart diseases,
stroke, depression and cancers will increase by 60% by 2020 and are likely to triple in Nigeria
and other sub-Saharan African countries in the next 50 years. According to the World Health
Report, non-communicable diseases including diabetes mellitus, arthritis and cardiovascular
diseases make up to about 22% of all deaths in the region in the year 2000; cardiovascular
diseases alone accounted for 9.2% of the total deaths [20]. Indeed, it has already been projected
that up to three quarters of the world’s hypertensive population will be in economically
developing countries by the year 2025 [7]. With increased prevalence rates and the resultant
greater economic and health burden [8–10], nations like China and Nigeria will feel the impact
mostly due to their population size.
Hypertension constitutes a greater percentage of all the referrals from other nonpsychiatric
units seeking for psychiatric evaluation in the University of Port Harcourt Teaching Hospital
(UPTH) [21]. Essential hypertension runs the features of chronicity, with subsequent need for
long-term medications, adverse effects on the central nervous system (CNS), high rate of
mortality and morbidity [10, 22, 23] and impact on emotion [24, 25] (the component that is
often neglected). In addition, patients with hypertension need extensive education, attitudinal
change, coping and healthy lifestyle, including diet and exercise. The need for these adjust‐
ments is imperative considering the immediate changes that usually accompany the diagnosis
of the condition. They include burden of the diseases, regular hospital visits, complications
arising from the primary illness and job adjustment. For these reasons, together with their
direct effects on the central nervous system (CNS), no doubt, the patients commonly present
with varying degrees of psychopathology [26–30]. Psychopathology is the inward or outward
manifestation of a disordered psychic system.
Essential hypertension is a severe, chronic systemic disease and is becoming increasingly
associated with psychiatric comorbidity, as high as 30–60% at present [31–36]. It carries
enormous burden on both the patients and the caregivers [37, 8–10]. Unfortunately, there
appears to be a general under-recognition or late recognition of, and in some cases poor
attention to, the psychiatric component by clinicians [38–42] particularly in this environment
[43]. This is often accompanied by increased severity and clinical deterioration of these
illnesses, poor management and prognosis with eventual high mortality rates. Late recognition
of mental disorders in hypertensive patients is related, among others, with diminished coping
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capacity at diagnosis, failure at primary prevention, poor antihypertensive adherence [44–47],
impairment in quality of life (QOL) [48–56], greater social burden, overall increases in
healthcare costs [57–59], and also higher mortality [8]. Also, psychological distress and lifestyle
variables among patients with hypertension are equally associated with noncompliance.
To further compound the problem is the co-existence of other medical conditions like diabetes
and obesity, with hypertension. Their presence further worsens the clinical outlook, compli‐
cates treatment and causes noncompliance [60]. Hypertension can, either singly or in associ‐
ation with other adverse psychosocial and clinical factors, predispose to psychiatric disorders.
Furthermore, some of the medications employed in the management of these conditions have
been associated with inherent neuropsychiatric complications [61, 62] either as direct side
effects, from drug interactions with psychoactive substances, from multiple drug therapy or
with other concomitantly administered drugs for other comorbid conditions.
Apart from the above aetiological links, a common pathway—sympathetic pathway [63–66]
—seems to mediate both essential hypertension and most anxiety disorders. It is equally
important to note that baseline adverse psychosocial factors, psychological distress or clearly
identified psychiatric conditions have been implicated as predictors of hypertension [67–72].
In light of the foregoing, there appears to be a bidirectional relationship between associated
psychiatric disorders and hypertension. This propensity to be associated with emotional
disturbances, with tendency to either predispose to or comorbid with psychiatric disorders,
has further increased the degree to which they affect the psychological well-being and quality
of life of the sufferers [73–80]. The focus of medical practice has always tended towards
relieving physical symptoms, in this case hypertension, which often neglects the huge impact
on the psychological well-being, psychiatric comorbidity and the overall quality of life of the
sufferers, often occasioning monumental health consequences [81, 82].
A prompt multidisciplinary approach involving evaluation, counselling and treatment of
mental disorders in hypertensive patients is becoming more important [83]. Therefore, the
determination of the nature and magnitude of psychiatric comorbidity, the additive effects on
psychological well-being and quality of life and emphasis on the need for mental health
component in the management of essential hypertension and other chronic medical conditions
form the areas of concern of this study.
2. Overview of hypertension
Hypertension is defined as a persistent elevation in blood pressure (BP) over an acceptable
upper limit of normal values of systolic and diastolic blood pressures [84]. Objectively,
hypertension is blood pressure persistently equal to or greater than 140/90 mmHg [85]. The
systolic pressure is the pressure at the peak of the heart’s contraction, while diastolic blood
pressure is the pressure when the heart relaxes. Blood pressure varies from moment to moment
and has a diurnal variation, being highest at 10 am and lowest at 3 am [86]. Hypertension may
be of unknown cause called essential hypertension or hyperpiesia [87] or may have an
underlying cause when it is known as secondary hypertension. Hypertension has been
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classified by the World Health Organization/International Society of Hypertension into mild,
moderate, severe and high normal [83].
Hypertension is a non-communicable chronic disease, often requiring long-term treatment.
The incidence may be on the increase as a result of increasing urbanisation and changing
lifestyles in the world [88–92]. Hypertension is regarded a major public health problem [29],
and it is an important threat to the health of adults in sub-Saharan Africa [93, 94].
Secondary hypertension indicates that the high blood pressure (HBP) is a result of another
underlying condition, such as kidney disease or tumours (adrenal adenoma or phaeochromo‐
cytoma). The pathogenesis of essential hypertension is not clearly understood [95, 96].
However, different investigators have proposed the kidney, peripheral resistance vessels and
the sympathetic nervous system as the seat of the primary abnormality [97]. In reality, the
problem is probably multifactorial. On the other hand, most mechanisms leading to secondary
hypertension are well understood [97]. Some studies have tried to implicate genetic and
environmental aetiologies to hypertension [98–101]. Disorder of the autonomic system, as in
the case of sympathetic nervous system overactivity and others include imbalance in the renin-
angiotensin-aldosterone system, chronic exposure to stress, chronic use of alcohol and other
associated medical diseases like diabetes.
3. Epidemiology of hypertension
The prevalence of hypertension is probably on the increase in developing countries, including
Nigeria, where adoption of western lifestyles and the stress of urbanisation, both of which are
expected to increase the morbidity associated with unhealthy lifestyles, are not on the decline
[102, 103]. The prevalence of hypertension depends on both racial composition of the popu‐
lation of the study and the criteria for defining the condition [104]. In Nigeria, it is the com‐
monest non-communicable disease; over 4.3 million Nigerians above the age of 15 years are
classified as being hypertensives [105, 106].
Risk factors have equally become important in the aetiology of hypertension. A study found
that as high as 62% of the total population of hypertensive lived with at least two risk factors,
mainly diabetes mellitus and alcohol use. Several other studies both in Nigeria and elsewhere
have also implicated diabetes, calcium salt and fat intake from consumption of processed food
[91], participating in jobs with minimal activities, obesity [92], consumption of caffeine [89,
108, 109] and alcohol [107], smoking and hypercholesterolemia [110, 111]. A proportion of the
diabetic population (20%) suffered from isolated systolic hypertension [106]. In a meta-analysis
of nine studies carried out in Nigeria with similar methodology, the authors [93, 112–115]
summarised the prevalence of hypertension in population of Nigeria for a 20-year period
(1990–2009), in which two reviewers, independently, were used during the selection process,
so as to reduce bias as much as possible.
In spite of the peculiarities found in studies on hypertension in different parts of the world, it
is important to note that in all areas, hypertension (HT) or high blood pressure (HBP) is a
heterogeneous set of disorders. Social and cultural factors have a direct aetiologic effect on
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hypertension, and these factors are responsible for most of the differences in disease prevalence
in different parts of the world. High blood pressure is a mass phenomenon responsible for
high morbidity and mortality affecting millions of people the world over [30], and with the
notable exception of a few non–salt-eating primitive societies, it occurs everywhere. Diseases
of the cardiovascular system are among the most important causes of morbidity in the
industrialised world [30, 116, 117], accounting for over one-third of all deaths in the United
States [118, 119]. A study [7] estimates a worldwide prevalence of between 10 and 15% of adult
populations to have high blood pressure which also agrees with findings in Africa [120].
However, other studies have reported a worldwide prevalence of 15–30% in adults [121].
Studies from the Western world identified five factors associated with hypertension:
increasing age, obesity, elevated pressure in blood relative, environment and race [116].
4. Hypertension and psychopathology
The relationship between hypertension and emotional disturbance or psychiatric morbidity
could be described as bidirectional, or better still, as taking the form of a vicious cycle. Apart
from the genetic components, persistent environmental stressors are well-known triggers for
hypertension [25, 31, 122]. They reset and over amplify the sympathetic outflow [62–65, 123].
The neurotransmitter that fuels the sympathetic pathway, noradrenaline, is consequently
overelaborated and becomes hyperactive. This causes both hypertension and anxiety disorders
including generalised anxiety disorder (GAD), panic disorder, acute stress disorder and PTSD.
On the other hand, the presence of anxiety alone can cause hypertension in predisposed
individuals [49, 50]. The chronicity of hypertension, persistent and recurrent symptoms,
impairment in functioning capacity, other adverse and enduring environmental psychosocial
burdens and even the thought of these can also in turn cause anxiety and may also quickly
drive the patient into depression, suicidal ideation or attempt and ultimately suicide. Long-
standing untreated depression in hypertensive patients can be complicated with psychosis
[23]. Also, hypertension can be complicated with cerebrovascular accident (CVA), with its
attendant neuropsychiatric sequelae including depression, anxiety, mild-to-severe cognitive
impairment, personality changes, vascular dementia and psychosis.
Lishman identified the interest of psychiatry in hypertension, besides the obvious consequen‐
ces of its central nervous system effects and noted:
1. The intriguing possibility of psychological factors as a part causation of essential hyper‐
tension.
2. Symptoms of hypertension like headache, fatigue, etc. appear to arise secondarily from
knowledge of the disorder than increased blood pressure per se.
3. Iatrogenic psychiatric effects can figure prominently in the use of antihypertensive drugs.
He suggested possible explanations including drugs taken, feeling ill and attendance to
hospital per se and possibly more pre-morbidly neurotic individuals becoming hypertensive
patients. Other various writers have also looked in depth at purely psychological attributes in
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hypertensive subjects either causally or effectually [106, 124]. Fundamental advances in the
understanding of hypertension from then have coincided with theories of anxiety states and
affective disorders suggesting catecholamines as mediators. These find common ground in
suggested mechanisms for producing increased arterial pressure [62–65, 123].
Studies have shown that stress-related situations, issue of job loss and unemployment [24],
prolonged difficulties, being under stress and people at war front were shown to have elevated
blood pressures [25, 31, 122]. It has been found that stress increases the level of cortisol which
causes increased deposition of arteriosclerotic deposits in the intima of blood vessels. These
depositions gradually narrow the lumen of the vessels, which in turn increases arterial
pressure resulting into hypertension. The same elevated cortisol has been implicated in
depression and also explains the high rate of depression associated with disorders that
primarily involve cortisol-like Cushing’s syndrome [125, 126]. It has also been suggested that
hypertensive individuals exhibit more aggressive traits than others and that these may be
hidden or suppressed, becoming manifest by abnormal elevation of blood pressure [127].
Psychosocial stressors, especially job-related stressors, predicted hypertension more strongly
in men than in women in these data as in those of other investigators [50]. Other potential
hypertension risk factors included social alienation and low level of education and ethnicity,
which are independent predictors of hypertension. Indicators of subjective distress and low
educational status, on the other hand, appeared more predictive of hypertension in women
than in men. The excess impact of psychosocial stress on the development of hypertension in
men compared with women may be related to sex differences in reactions to cardiovascular
stress reactivity [127].
Some other studies that have examined the association of hypertension with psychological
distress, such as anxiety and depressive symptoms, have produced mixed findings. Several
studies have reported positive associations [128, 129], whereas others have observed weak or
no associations. Other numerous studies have produced evidence that patients with depres‐
sion have an increased risk of developing cardiovascular disease [48]. Also, depression in
untreated hypertension might increase risk of developing cardiovascular disease. There is even
some evidence to suggest lower blood pressure (BP) in participants with depressive or anxiety
disorders. These areas of uncertainty call for further research (longitudinal) to evaluate the
true associations between mental disorders and hypertension.
The findings of other studies that depressive disorder was associated with lower systolic blood
pressure (SBP), although the use of tricyclic antidepressants was associated with greater risk
of hypertension, may simply correspond with increased risk of weight gain associated with
these agents [130]. Similar findings have been made with psychotropic medications. These
studies are limited by their cross-sectional design, which made it difficult to infer causality or
determine the direction of the observed relationship between hypertension and psychological
distress. A related issue is the effect of labelling patients as hypertensive. Several studies have
suggested that individuals ‘labelled’ as hypertensive might adopt a sick role that can nega‐
tively affect quality of life [74–79]. For this reason, the association between hypertension and
psychological distress may be because of a direct effect of the BP itself, adverse effects of
treatment or the consequences of labelling.
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Another study also found that health-related quality of life, including physical functioning,
vitality, mental health and pain thresholds, was better in unaware compared with aware
hypertensive participants [78]. Several mechanisms have been postulated to explain the effects
of labelling. Some evidence suggests that the act of labelling somebody as hypertensive can
cause increases in sympathetic activity during mental stress [123], which might partly explain
the reason for the poor mental health of patients with hypertension. In a study of 214 normo‐
tensive and mildly hypertensive participants, the perception of being hypertensive was
associated with greater anxiety during clinic BP measurement and may be due to the white
coat effect [131].
Another study also observed direct associations between the use of alcohol (daily >14 g intake
of ethanol) and kola nut consumption in men and isolated systolic hypertension [124]. The
survey showed that over 10% of the population taking kola nuts (at least one in 2 days)
and/or alcohol is hypertensive. Caffeine has been identified as a significant cause of hyper‐
tension [79]. The authors [79] therefore concluded that programmes to improve treatment of
hypertension should not only focus on lifestyle variables like smoking and alcohol, but they
should also include the identification and treatment of substance abuse and dependence
disorders.
Besides anxiety and depression, a range of other psychiatric problems may occur following
cerebrovascular accident resulting from hypertension. They include cognitive disorders and
personality changes [127], especially with the involvement of the right hemisphere. In fact,
untreated hypertension can equally cause cognitive impairment, which is commonly seen in
organic psychiatry [97]. A study done in two communities in Ibadan metropolis, Nigeria, by
Ogunniyi and Baiyewu found a high rate of incident (vascular) dementia with psychological
and behavioural components as complications of hypertension [43]. Studies have also found
out the association between hypertension and erectile dysfunction in men. A study noted 1%
of psychogenic impotence and 1% secondary to the effect of some antihypertensive drugs like
methyldopa and reserpine [29].
This study was therefore designed to evaluate the sociodemographic and clinical correlates of
psychiatric comorbidity in hypertensive patients. This, no doubt, would be of immense
relevance to the practice of consultation liaison psychiatry in the West African subregion and
contribute to the corpus of knowledge on chronic medical conditions and aid care/service
providers to plan better management strategies that will also accord premium to the psycho‐
logical component and well-being of these patients. Impairments, disabilities and handicaps
from chronic conditions may thus be limited and patients’ dignity and functional capacity
enhanced.
5. Aim
The study was to determine the pattern and prevalence of psychiatric comorbidity and quality
of life in subjects with essential hypertension.
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6. Methodology
In this cross-sectional study, following ethical approval from the hospital and informed
consent from the participants, 360 subjects making up the study group were recruited based
on the study’s inclusion and exclusion criteria, after a pilot study for both groups. In addition,
the hypertensives were screened for human immunodeficiency virus (HIV) infection. Subjects
were further administered with the study’s instruments including the sociodemographic
questionnaire, General Health Questionnaire, version 12 (GHQ-12), World Health Organiza‐
tion Composite International Diagnostic Interview (WHOCIDI) and the brief version of the
WHO Quality of Life (WHOQOL-Bref) instrument. Severity of hypertension was determined
using the modern classification by the WHO/International Society of Hypertension into mild,
moderate and severe. Those considered suitable for the study were patients who had been
seen and diagnosed as having essential hypertension by the consultant family physicians and
internists.
The hypertensive patients have all had basic investigations: i.e. full blood count, blood urea
and electrolytes estimation and urinalysis, in most cases. In addition, some had electrocardio‐
grams (ECG), chest X-rays, serum cholesterol, uric acid, creatinine and creatinine clearance
estimations. Investigation results were all recorded in the case notes. Hypertensive patients
with primary myocardial or valvular disease, cardiac failure or renal failure or who had a
stroke or coronary heart disease, diabetes, asthma or other chronic illnesses or those found to
be acutely ill were excluded. Patients were required to have been diagnosed for at least the
past 1 year and have had at least 6 months of treatments. The data were analysed using the
Statistical Package for Social Sciences version 16 statistical package. Confidence interval was
set at 95%, while p-value of less than 0.05 was considered statistically significant.
7. Study instruments
The following instruments were used in this study:
• Sociodemographic/clinical questionnaire
• General Health Questionnaire, version 12 (GHQ-12)
• World Health Organization Composite International Diagnostic Interview (WHOCIDI)
8. Results
8.1. Sociodemographic and clinical correlates of psychiatric morbidity in study group
Out of the 360 subjects with essential hypertension who fulfilled the inclusion criteria, 141
(39.2%) were males and 219 (60.8%) females. The mean age for the study group (hypertensives)
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was 45.57 years. More than half of all the subjects 257 (71.4%) were married. The majority
(78.0%) had attained at least a secondary level of education.
Variables  Essential hypertensive 
  Total Psychiatric diagnosis No psychiatric diagnosis Statistical analysis 
Age X2 = 3.27
df = 4
p = 0.35
<20 0 0 (0.0%) 0 (0.0%)
20–29 16 9 (3.8%) 7 (5.6%)
30–39 77 49 (20.8%) 28 (22.6%)
40–49 132 82 (34.7%) 50 (40.3%)
≥50 135 96 (40.7%) 39 (31.5%)
360 236 (65.6%) 124 (34.43%)
Sex X2 = 1.52
df = 1
p = 0.22
Male 141 87 (36.9%) 54 (43.5%)
Female 219 149 (63.1%) 70 (56.5%)
Marital status X2 = 20.94
df = 4
p < 0.001
Married 257 153 (64.8%) 104 (83.9%)
Single 38 25 (10.6) 13 (105.5%)
Divorced 3 8 (1.30%) 0 (0.0%)
Separated 8 8 (3.4%) 0 (0.0%)
Widowed 54 47 (19.9%) 7 (5.6%)
Education X2 = 2.78
df = 3
p = 0.43
None 17 10 (4.2%) 7 (5.6%)
Primary 76 55 (23.3%) 21 (16.9%)
Secondary 128 85 (36.0%) 43 (34.7%)
Tertiary 139 86 (36.4) 53 (42.7%)
Tribe X2 = 0.43
df = 2
p = 0.81
Hausa 7 3 (1%) 4 (1.1%)
Ibo 75 41 (11.4%) 34 (9.4%)
Yoruba 20 10 (2.8%) 10 (2.8%)
Ijaw 83 52 (14.4%) 31 (8.6%)
Ogoni 62 29 (8.1%) 33 (9.2%)
Ikwerre 79 48 (13.3%) 31 (8.6%)
Others 24 16 (4.4%) 8 (2.2%)
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Variables  Essential hypertensive 
  Total Psychiatric diagnosis No psychiatric diagnosis Statistical analysis 
Average monthly income X2 = 23.86
df = 3
p < 0.001
Low 83 54 (24.8%) 29 (24.2%)
Average 159 104 (47.7%) 54 (45.0)
High 97 60 (27.5%) 37(30.8)
Reaction to diagnosis X2 = 14.41
df = 10
p = 0.16
Normal 38 18 (7.6%) 20 (16.1%)
Sad 175 101 (42.8%) 74 (59.7%)
Very sad 146 116 (49.2%) 30 (24.2%)
Wish to die 1 1 (0.4%) 0 (0.0%)
Mode of getting drugs X2 = 13.09
df = 3
p = 0.57
From the government 106 42 (11.7%) 64 (17.8%)
Self-purchase 202 146 (40.6%) 56 (15.6%)
Both 52 35 (9.7%) 17 (4.7%)
Source of support X2 = 15.06
df = 3
p = 0.33
Charity organisation 14 9 (2.5%) 5 (1.4%)
Fiends 36 27 (7.5%) 9 (2.5%)
Relatives 92 60 (16.7%) 32 (8.9%)
None 218 143 (39.8%) 75 (20.8%)
Domestic situation X2 = 12.41
df = 3
p = 0.51
Partner 37 22 (6.1%) 15 (4.2%)
Family 307 213 (59.2%) 94 (26.1%)
Friends 7 3 (0.8%) 4 (1.1%)
None 9 5 (1.4%) 4 (1.1%)
Blood pressure X2 = 16.40
df = 3
p = 0.001
BP within normal range 0 0 (0%) 0 (0%)
Mild hypertension 119 49 (13.7%) 70 (19.4%)
Moderate hypertension 161 114 (31.7%) 47 (13.1%)
Severe hypertension 80 73 (20.3%) 7 (1.9%)
Occupation X2 = 17.63
df = 10
p = 0.82
Managers 5 3 (1.3%) 2 (1.6%)
Professionals 15 5 (2.0%) 10 (2.8%)
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Variables  Essential hypertensive 
  Total Psychiatric diagnosis No psychiatric diagnosis Statistical analysis 
Technicians and associate
professionals
30 23 (7.7%) 7 (5.6%)
Clerical support workers 46 32 (13.6%) 14 (11.3%)
Service and sales workers 29 18 (7.6%) 11 (8.9%)
Skilled agricultural forestry and
fishery workers
30 23 (9.7%) 7 (5.6%)
Craft and related trade workers 54 33 (13.6%) 22 (17.27%)
Plant and machine operators and
assemblers
47 31 (13.1%) 16 (12.9%)
Elementary occupation 72 50 (21.2%) 22 (21.8%)
Armed forces occupation 3 1 (0.4%) 2 (1.6%)
Unemployed 22 17 (7.2%) 5 (4.0%)
Age of onset of disease X2 = 1.89
df =3
p = 0.60
20–29 27 18 (7.6%) 9 (7.3%)
30–39 102 62 (26.3%) 40 (32.3%)
40–49 169 112 (47.5%) 57 (46.0%)
>50 62 44 (18.6%) 18 (14.5%)
Duration of illness X2 = 0.63
df = 2
p = 0.73
1–5 316 208 (88.1%) 108 (87.1%)
6–10 30 18 (7.6%) 12 (9.7%)
11 and above 14 10 (4.2%) 4 (3.2%)
Duration of treatment X2 = 0.91
df = 3
p = 0.82
<1 74 46 (19.5%) 28 (22.6%)
1–5 242 162 (68.6%) 80 (64.5%)
6–10 31 19 (8.1%) 12 (9.7%)
>10 13 9 (3.8%) 4 (3.2%)
Missed treatment X2 = 1.89
df = 3
p = 0.003
Yes 73 61 (16.9%) 12 (3.3%)
No 287 171 (47.5%) 116 (32.2%)
STIGMA X2 =2.13
df = 1
p = 0.15
Yes 4 4 (1.7%) 0 (0.0%)
No 356 232 (98.3%) 124 (100.0%)
Table 1. Sociodemographic variables and psychiatric comorbidity among hypertensives.
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More than one quarter of all the subjects, 241 (66.9%), were within low to average income range
of less than 10,000–30,000 naira monthly. The majority, 169 (46.9%), had their onset of illness
at the age range of 40–49 years. Persons who were married were significantly more likely to
have a psychiatric comorbidity (p < 0.001). Also, those who reacted with either ‘very sad’ or a
‘wish to die’ when they received the diagnosis of the medical conditions were more likely to
have psychiatric comorbidity (p = 0.001). See Table 1.
8.2. Pattern and prevalence of psychiatry morbidity in subjects with essential hypertension
A total of 232 (64.4%) subjects had associated psychiatric comorbidity, while 128 (35.5%) had
no psychiatric diagnosis. Out of the total number with psychiatric comorbidity, 106 (29.4%)
had a depressive illness, generalised anxiety disorder (GAD) was diagnosed in 58 (16.2%)
patients, 32 (9.3%) patients had sexual dysfunction out of which 27 (7.5%) had male erectile
dysfunction, while 5 (1.4%) had hyposexual dysfunction and was diagnosed all in females (see
Figure 1).
Figure 1. Bar chart showing the pattern and prevalence of psychiatric morbidity among persons with essential hyper‐
tension.
It is important to note that 20 (5.6%) patients were diagnosed with more than one condition.
Erectile dysfunction and substance abuse were diagnosed in one patient; one respondent had
GAD, substance abuse and erectile dysfunction; five respondents had GAD and hyposexual
dysfunction; six had GAD and male erectile dysfunction, two had mixed anxiety and
depression and male erectile dysfunction; and five had depressive illness and male erectile
dysfunction. This accounted for the excess above 590 patients if the total diagnoses are summed
up (see Table 2).
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S/N Diagnosis  Essential hypertension 
    Freq.  Male  Female 
1  Substance abuse/male erectile dysfunction  1 (0.3%)  1 (1.7%)  0 (0.0%) 
2  Generalise anxiety disorder/substance abuse/male erectile dysfunction  1 (0.3)  1 (1.7%)  0 (0.0%) 
3  Generalised anxiety disorder  36 (10.0%)  17 (11.8%) 19 (8.8%) 
4  Generalised anxiety disorder with somatic features  10 (2.8%)  4 (6.8%)  6 (2.8%) 
5  Generalised anxiety disorder  5 (1.4%)  0 (0.0%)  5 (2.3%) 
6  Generalised anxiety disorder/male erectile dysfunction  6 (1.7%)  6 (4.2%)  0 (0.0%) 
7  Mixed anxiety and depression/male erectile dysfunction  2 (0.6%)  2 (3.4%)  0 (0.0%) 
8  Moderate depression/male erectile dysfunction  4 (1.1%)  4 (6.8%)  0 (0.0%) 
9  Mild depression/male erectile dysfunction  1 (0.3%)  1 (1.7%)  0 (0.0%) 
10  Male erectile dysfunction  12 (3.3%)  12 (7.3%)  0 (0.0%) 
11  Mild depressive disorders  35 (9.7%)  5 (3.5%)  30 (13.9%) 
12  Dysthymia  1 (0.3%)  0 (0.0%)  1 (0.5%) 
13  Mild depression with anxiety features  10 (2.8%)  2 (3.4%)  8 (3.7%) 
14  Mild depression with somatic features  7 (1.9%)  1 (1.7%)  6 (2.8%) 
15  Mixed anxiety and depressive disorders  21 (5.8%)  5 (3.5%)  16 (7.4%) 
16  Moderate depressive disorders  36 (10.0%)  8 (3.6%)  28 (3.0%) 
17  Panic disorder without agoraphobia  4 (1.1%)  2 (3.4%)  2 (1.0%) 
18  Severe depression with psychotic features  8 (2.2%)  2 (3.4%)  6 (2.8%) 
19  Personality disorders  5 (1.4%)  4 (6.8%)  1 (0.5%) 
20  Substance abuse  6 (1.7%)  5 (3.5%)  1 (0.5%) 
21  Nil (no diagnosis)  128 (35.5%) 57 (15.8%) 71 (19.7%) 
  Total  360 (100%)  144 (39.5)  216 (32.9%) 
Table 2. Pattern and prevalence of psychiatry morbidity in subjects with essential hypertension.
9. Association of psychiatric comorbidity with quality of life in persons
with essential hypertension
From the study, psychiatric comorbidity was negatively statistically significantly associated
with QOL in all domains except in General Health Facet in both medical conditions. Among
the hypertensives patients, those with psychiatric comorbidity performed better on psycho‐
logical and social domains (see Table 3).
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Domains of
QOL 
Quality of life in persons with essential hypertension 
  Quality of life of all
hypertensive
patients 
Psychiatric
comorbidity 
No psychiatric
comorbidity 
Statistical analysis 
Physical domain  50.97 ± 14.671  45.98 ± 13.064  60.46 ± 12.788  t = −10.07 df = 358 p < 0.001 
Psychological
domain 
54.20 ± 22.186  56.60 ± 24.914  61.05 ± 13.362  t = −4.35 df = 358 p < 0.001 
Social domain  54.51 ± 26.13  48.06 ± 26.114  66.80 ± 21.378  t = − 6.87 df = 358 p < 0.001 
Environment
domain 
50.01 ± 16.91  44.95 ± 14.831  59.62 ± 16.503  t = −8.57 df = 358 p < 0.001 
General health
facet 
49.34 ± 22.44  47.98 ± 21.896  51.91 ± 23.319  t = −1.58 df = 358 p < 0.001 
Table 3. Association of psychiatric morbidity with quality of life in persons with essential hypertension.
10. Discussion
The study on the psychiatric comorbidities associated with essential hypertension was
conceptualised mainly from the observation of the relatively high frequency with which
requests for psychiatric consultation were being received over time from other clinical
departments in UPTH, particularly internal medicine. The observation was later confirmed by
a study [43]. The study was, thus, started with the main objectives of determining the pattern
and prevalence of psychiatric morbidity among persons with essential hypertension attending
the outpatients clinic of UPTH. A cross-sectional design was adopted, with a sequential use of
four study instruments, followed by analysis of data using the various statistical methods.
From the study, the prevalence of essential hypertension was noted to be increasing with age
and was about twice higher, in the age groups 40–49 and 50 and above, compared to age group
of 30–39, and about six times higher compared with age group 20–29. This result is consistent
with earlier studies which reported that about 4.3 million Nigerians above the age of 15 years
are classified as being hypertensive. Furthermore, the prevalence has been said to be related
to age, particularly in females, with a substantial increase occurring after the age of 50 [36].
Though essential hypertension commonly starts in middle age, the illness may progressively
become worse with attendant incapacitating symptoms that may infringe on the functional
capacity of the individual and thereby lowering the quality of life. Africans usually seek
medical attention mostly when illness has worsened with disabling symptoms, and in most
cases late, in spite of awareness of the diagnosis. This is particularly more so for essential
hypertension. Moreover, cultural factors, poverty and inaccessibility to healthcare facilities
often contribute to this delay. This could also explain the over-representation of the older age
group in the hypertensive patients in this study, who are more superstitious, poor and with
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low-income capacity and hence unable to seek health care, particularly timely. Furthermore,
essential hypertension is a chronic disease, and most of the respondents diagnosed over 5–10
years ago are still on maintenance antihypertensive therapy.
On the other hand, the rising prevalence of hypertension with age could be a reflection of
exposure to enduring stressors, poor dietary habit, lack of exercise and other culturally
permissible hazardous lifestyle [36].
The most prevalent age of onset of hypertension was ages 40–49, with 169 respondents or
46.9%. This was in agreement with other studies, which had established that the illness is
commonest after 40 years. It is interesting to note that the number of patients steadily increased
with increasing age of onset of illness with a sharp decrease after the age of 50. Hypertension
beginning after the age of 50 years is most likely to be secondary hypertension [23]. This result
is therefore in consonant with the methodology adopted in this study, where all those with
any other concurrent medical illnesses were excluded in other not to introduce bias. However,
it was difficult for most of the respondents to know exactly the age of onset of disease since
majority only became aware of the diagnosis during their first or routine hospital visits.
Females predominated in the study with 60.8%, and although essential hypertension is more
common in males, females may have been over-represented in this study due to two reasons.
First, African females tend to have lower blood pressure than males early in life with a reversal
of the trend after the ages 45–50 years [35, 36]. This may be due to hormonal changes associated
with the preparation for or actual menopause occurring in this age group, coupled with the
increasing family and domestic (stressors) responsibilities shouldered by married females in
this age group. Interestingly, in this study, there was high prevalence of the married females
in both groups. Another probable reason for the predominance of females in this study is that
females are more willing and likely to volunteer their symptoms easier than males and
consequently tend to have better health-seeking behaviours.
The married group was over-represented in the study (71.4%). This preponderance might be
due to low rates of divorce and separation, which may reflect a dominance of Christianity in
the study environment. Furthermore, widows constituted a significant percentage (15%)
among the hypertensives, next to the married group. Widowhood, no doubt, hurts and often
results in severe emotional trauma, particularly when it is sudden and early in life. More than
half of the subjects who were single (10.6%) were above the age of 30 years, many of whom
were unemployed. In Africa, due to sociocultural values, a female not yet married at the age
of 30 years and above calls for concern not only to her but also to her family members. Majority
of the separated group were females. Although lower rates of psychiatric comorbidities were
found among these categories, both separation and divorce are capable of impacting enormous
psychological trauma in affected individuals.
Also from the study, it was found that more of each of the categories—married, separated and
widowed—had more psychiatric comorbidity among patients with hypertension. A possible
explanation could be that in hypertension, marital difficulties, separation and even widow‐
hood may serve as baseline psychosocial factors that may act either singly or in synergy with
the medical stressor (hypertension) to cause psychiatric comorbidity. The presence of these
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psychosocial stressors alone can equally predispose to hypertension. Thus, in hypertension,
psychological stressors are both causal and effectual.
Most of the subjects in this study had attained various levels of formal education especially
secondary and tertiary. Perhaps the influence of westernisation and urbanisation in Rivers
State, Niger Delta and Nigeria might have played an important role. Furthermore, the
cosmopolitan nature of Port Harcourt, domiciling majority of ethnic groups in Nigeria, with
over 50% of Nigeria’s oil and gas business, makes education a priority. A good number (39%)
of the subjects with hypertension had tertiary education. The fact that they were educated may
have increased their chances of employment and possibly ability to seek quality health care
and timely, too. It is equally important to note that perhaps the older one becomes, and
probably with more education, the more his or her socioeconomic and family responsibilities,
with their accompanying stressors.
A number of studies have implicated environmental stressors as important aetiological factors
in high blood pressure, particularly in already genetically predisposed individuals [82].
Occupational environments in Nigeria had remained stressful due to lack of job security and
poor wages and remunerations, confronting countless demands from members of the family
in a poverty-ravaged economy such as ours. This is supported by the fact that the percentage
of females with tertiary education was significantly less compared to other educational levels.
The incidence of psychiatric comorbidity was lowest among those with tertiary education.
Hence, education tended to have some protective influence on the psyche of the study subjects.
Expectedly, those with higher level of education were more likely to secure better employment,
earn better income and have better access to quality health care. Thus, in this study, results
showed that being employed correlated positively, while unemployment correlated negatively
with occurrence of psychiatric comorbidity.
From the study, essential hypertension was associated more with low income. Stable income,
no doubt, is an important stabilising factor for any chronic illness. In this study, income level
negatively correlated with psychiatric comorbidity in hypertension. The higher the income
level, the lower the prevalence of psychiatric illness in hypertension. Among the hypertensives,
there was preponderance of older adults; however, as it has to do with income level, it appears
to be a combined effect of both income and age in the study.
African extended family may also be contributory. Sharing the burden of disease by relatives
in the African extended family system may be an advantage to the outcome of chronic illnesses
like hypertension, as it tends to distribute responsibility from such patients to other family
members. This was evident from this study where 85% of hypertensives live with their
supportive family members. Adequate social support has been identified as a key factor in
relieving or decreasing psychosocial burden associated with chronic medical conditions.
Expectedly, the longer the duration of these illnesses, the more likelihood of developing
psychopathology. Interestingly, however, the reverse was observed in this study, as psychi‐
atric comorbidity steadily decreased with increasing duration of illness. This might suggest
that with the passage of time, one tended to absorb the initial shock of diagnosis and had
adequately readjusted to the medical condition. Secondly, they might have stabilised on
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medications. The high rate of psychiatric illnesses among those in treatment between 1 and 5
years could probably reflect an over-representation of subjects in this category ab initio. Also,
the effect of advancing age might have played a role as many would have died from compli‐
cations of the illness. This was reflected in this study as subjects in the category of duration of
treatment greater than 10 years were fewer. Mortality rates in this medical condition have
remained high [93].
The reduced rate of psychiatric comorbidity among the category that has had treatment for 6
years and above could suggest that most of the medications being used in these clinics in the
treatment of patients with essential hypertension even though they potentially may be
associated with neuropsychiatric side effects [82] were cautiously used and properly moni‐
tored. This might have resulted into minimal rate of psychiatric side effects even with
prolonged use.
From the results of this present study, the prevalence of psychiatric morbidity in the hyper‐
tensives was 64.4%. This was slightly higher than results from previous studies [62]. Ohene,
in his study in Benin City, found a prevalence of 35% psychiatric morbidity among persons
with essential hypertension [62]. Although these results seem to be far apart, the difference
might reflect the increasing environmental stressors and economic hardship, increasing spate
of insecurity in Nigeria and particularly in the Niger Delta, which has significantly worsened
over the last 10 years.
Hypertension alone can present with psychiatric morbidity, and this may be aggravated by
adverse environmental factors. Adverse environmental factors can in turn predispose to
essential hypertension and mental illness. Indeed, this relationship describes a sustained
vicious circle. Another possible reason for the observed difference was that in the study by
Ohene [62], GHQ-30 was used which is a less-sensitive version when compared with GHQ-12
(used in this study). Thirdly, the sample size was smaller, i.e. 40 patients compared with 360
hypertensives used in this study. The higher the sample size, the higher the likelihood of
diagnosis of psychiatric morbidity. Furthermore, several studies have suggested that hospital-
based treatment of hypertensives tends to be associated with higher neuroticism and levels of
psychiatric morbidity than their counterparts on community-based treatment. Another
plausible reason could be the use of some antihypertensive particularly calcium channel
blockers and α-methyldopa, implicated recently in psychiatry comorbidity among patients on
treatment for hypertension.
Out of the total number with psychiatric illness, 232 (64.4%), depression was significantly the
commonest with 29.4% as against 16% in Ohene’s study [62]. Depression was mostly the mild
and moderate types with few cases presenting with psychotic features which were mostly
mood congruent. This might also be due to reasons earlier given for overall psychiatric
disorders. Hypertension presents with very disabling symptoms, which could impair the
functional capability of the sufferer. This, coupled with other adverse depressogenic environ‐
mental factors, might predispose the patient to depressive illness. There was significant
predominance of females with depression. This finding, which is consistent with the gender
distribution of depression, may equally reflect the willingness of the female gender to
volunteer information on their health, hence, better health-seeking behaviour. Hypertensive
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disease, which carries the risk of both physical and emotional burden, is likely to affect the
mood-regulating centre of the brain, i.e. the limbic system.
The prevalence of generalised anxiety disorder was 16.1% in this study. Previous study had
found 12%. This could possibly be more frequent. The effect of propranolol and benzodiaze‐
pines (bromazepam and diazepam), which are commonly used medications in the General
Outpatient Department, may have been responsible for the relatively low prevalence. Males
were 48.2% and females 51.8%. Again, the observed gender bias is in line with existing
literature. Earlier studies have suggested that hypertensives were more neurotic, more
insecure, more conservative and more tense.
Hypertension and generalised anxiety disorder are somewhat similar illnesses, sharing
common pathway—the sympathetic pathway. It is for this reason that medications like beta
blockers such as propranolol and some benzodiazepine that act by dampening the activity of
the sympathetic pathway have comparable usefulness in both disease conditions. Another
reason to ‘drive home’ the relationship between hypertension and anxiety is that fundamental
advances in the understanding of hypertension have coincided with the theories of anxiety
states and affective disorders, suggesting catecholamines—particularly known here is
noradrenaline [11].
This finds common ground in suggested mechanism for producing increased arterial pressure
and neurotic states [11]. This is also consistent with the study by Kidson [94], who argued that
higher neurotic scores of his hypertensive outpatients were due to a ‘reactive state’ occurring
in them contrary to other study [113], which reported the absence of neuroticism among newly
hypertensives and suggested that drug treatment could cause the observed neurosis. However,
in this study, the inclusion criteria of 1 year duration of illness stand to disprove this, and it
also appears that most of the hypertensives with diagnosis of anxiety were not due to their
medication, and most were having one psychosocial stressor or the other that may either be
responsible for or worsen the hypertension, anxiety or even both.
Panic disorder was diagnosed in 1.1% of hypertensive patients in this study. Many workers
have consistently established that most of the major deleterious effects of high blood pressure
are in the heart, blood vessels, kidneys and brain [11]. Therefore, with the strong connection
between the heart and cardiovascular system, hypertension and the psyche, diagnosis of panic
disorder in hypertensive subjects might not be a surprising finding. In fact, other names that
have been given to anxiety neurosis (now obsolete) include cardiac neurosis, irritable heart
syndrome, soldier’s heart, nervous tachycardia, vasomotor neurosis, vasoregulatory asthenia
and disordered action of heart, among others. Strikingly, these names mainly further imply
the close and strong association between the heart or cardiovascular system and anxiety states.
Considering the fact that psychiatric morbidity was most prevalent in the unemployed,
elementary and low-income workers, separated and divorced, all baseline psychosocial
factors, capable of causing depressive illness, anxiety disorders and other mental illnesses,
hypertension is commonly associated with stressful conditions. This is in line with findings
from other studies which also showed that some common aetiological factors like stress-related
situations, issues of job loss and unemployment, prolonged difficulties and people at war front
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were shown to have hypertension and anxiety [100]. It has been found that stress, which
potentially causes anxiety, also increases the level of cortisol which in turn causes increased
deposition of arteriosclerotic deposits in the intima of blood vessels [11]. These deposits
gradually narrow the lumen of the vessels. This in turn increases arterial pressure resulting in
hypertension [11].
Sexual dysfunction was diagnosed in 9.0% of hypertensive patients. Of this, 84% had male
erectile dysfunction, while 16% who were all females had hyposexual dysfunction. Hyposex‐
ual desire disorder (HSDD) is sexual dysfunction with decreased libido, lack of sexual
motivation and decreased sexual fantasies. Some studies have found associations between
hypertension and erectile dysfunction in men, while others have implicated effects of some
antihypertensive drugs like methyldopa and reserpine [50, 62], in addition to psychogenic
impotence. However, in this study no patient was being treated with reserpine, and of the 27
males with erectile dysfunction, only negligible three subjects were on methyldopa.
Another diagnosis that was made among eight of the hypertensives was substance abuse. More
than 80% of them had alcohol-related disorder with the male-to-female ratio of 7:1. Although
the gender gap was wide, substance abuse generally is commoner among males than females.
There is a bidirectional relationship between substance abuse and hypertension, i.e. substance
abuse particularly alcohol can cause hypertension while hypertension, on the other hand, can
precipitate substance abuse due to frustration [70, 71]. People with hypertension tend to abuse
substance mainly to self-medicate their depression or to abate the many anxiety or anxiety-
like symptoms that characterised hypertension, hence the use of propranolol and diazepam
which have anxiolytic effects.
Personality disorder was seen in 5% of the hypertensive subjects. The concept of type A
behaviour pattern (TABP), also referred to as type A personality, which appears fairly well
established as a strong correlate of coronary heart disease (CHD), strongly supports a rela‐
tionship between hypertension and personality disorder [93]. High blood pressure (HBP) is
identified as major risk factor to CHD, which is reported to be on the increase in Nigeria.
However, the present study found a low rate of personality disorder.
Hypertensive subjects with more than one psychiatric morbidity were seen in this study.
Twelve percent had both GAD and sexual dysfunction, while 8% had both major depression
and sexual dysfunction. This equally agrees with the multifactorial aetiological basis of
essential hypertensive with environmental stressors playing as much significant role as genetic
factors.
For quality of life among patients with hypertension, studies in western countries have shown
inconsistent findings. There are no local studies to compare with the present study where both
psychiatric comorbidity and QOL were studied together. However, a study that compared
QOL of epileptics, schizophrenics and hypertensives found that the last fared poorly on all
domains except on overall quality of life where they all faired equally. Some authors have
opined that quality of life will be poor in the developing countries like Nigeria where factors
of finances, social relationships, health and personal safety are considered to be poor. Hyper‐
tension in adults has a high impact on the economy and with consequent low quality of life of
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individuals. The results in this study are consistent with many studies elsewhere [27]. It also
agrees with a population-based study, which found a lower health status in the hypertensives
compared with individuals free from hypertension. This finding varied a little from previous
studies where all domains of QOL except domain 4 (environment) and health satisfaction were
affected by psychiatric comorbidity.
11. Conclusion/recommendations
The findings of this study support the impression that essential hypertension is a chronic
debilitating illness, associated with psychiatric comorbidity. In both groups, being divorced
was associated with lower QOL in some domains. The results support the call that the
management of patients with hypertension should include attention to their mental health
status and subjective quality of life in order to enhance the quality of care.
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